SCHEMBL27214760

SCHEMBL27214760

O=[N+]([O-])c1ccc(-c2c3ccccc3c(-c3ccc([N+](=O)[O-])cc3)c3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
LMNA P02545 2/20 0.56
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
HTT P42858 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
RECQL P46063 1/20 0.54
MAPT P10636 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
POLB P06746 1/20 0.52
MAPK1 P28482 1/20 0.52
TNKS O95271 2/20 0.50
TNKS2 Q9H2K2 2/20 0.50
PARP2 Q9UGN5 2/20 0.50
PARP1 P09874 1/20 0.50
CSNK2A2 P19784 1/20 0.50
CSNK2B P67870 1/20 0.50
CSNK2A1 P68400 1/20 0.50
APP P05067 1/20 0.50
L3MBTL1 Q9Y468 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13374625 0.91 MEN1 (0.48) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL23235652 0.87 CYP3A4 (0.56) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL28573853 0.85 MEN1 (0.49) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL9666436 0.84 ALDH1A1 (0.65) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL13374621 0.81 MEN1 (0.57) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL8986931 0.80 MEN1 (0.46) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL25187033 0.79 MAPK1 (0.74) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL167524 0.79 MAPK1 (0.74) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL28198 0.78 CA1 (0.67) ALDH1A1LMNARECQLMAPTTDP1
SCHEMBL6423919 0.78 CA1 (0.67) ALDH1A1LMNARECQLMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240151993-A1 ELECTRON WITHDRAWING GROUP (EWG)-CONTAINING ORGANIC MOLECULES FOR IMPROVED OPTICAL PROPERTIES IN AR/VR COMPONENTS META PLATFORMS TECHNOLOGIES, LLC 2024-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240151993-A1 ELECTRON WITHDRAWING GROUP (EWG)-CONTAINING ORGANIC MOLECULES FOR IMPROVED OPTICAL PROPERTIES IN AR/VR COMPONENTS AR, OR10J3, ESRRG ALDH1A1 2350/4885LMNA 3078/4885MEN1 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.